Avai Bio (AVAI) Total Debt (2018 - 2023)

Avai Bio has disclosed Total Debt across 6 years of filings, most recently posting $99000.0 for Q4 2023.

• Total Debt for Q4 2023 came in at $99000.0, down 54.31% year-over-year; the trailing twelve-month figure through Dec 2023 was $99000.0 (down 54.31% YoY), and the FY2023 annual result was $198000.0, up 100.0% from the prior year.
• Total Debt came in at $99000.0 for Q4 2023 at Avai Bio, roughly flat from $99000.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $216668.0 in Q4 2022 to a low of -$480.0 in Q2 2020.
• The 5-year median for Total Debt is $83567.5 (2019), against an average of $80878.5.
• Across the five-year window, Total Debt sank 100.47% in 2020 and surged 2638.67% in 2022, its largest moves.
• Avai Bio's Total Debt stood at $186984.0 in 2019, then slumped by 84.42% to $29141.0 in 2020, then surged by 387.57% to $142082.0 in 2021, then surged by 52.5% to $216668.0 in 2022, then sank by 54.31% to $99000.0 in 2023.
• The last three Total Debt figures came in at $99000.0 (Q4 2023), $99000.0 (Q3 2023), and $99000.0 (Q2 2023), per Business Quant data.